Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | MMP2 | P08253 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | CFTR | P13569 | 1/20 | 0.40 |
| ▸ | TAS2R14 | Q9NYV8 | 2/20 | 0.40 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA7 | P43166 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.39 |
| ▸ | FABP4 | P15090 | 1/20 | 0.39 |
| ▸ | PLK1 | P53350 | 1/20 | 0.39 |
| ▸ | PLK3 | Q9H4B4 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL4454152 | 0.98 | HSD17B10 (0.41) | HSD17B10HTTMMP2ALDH1A1HPGD | |
| Water SCHEMBL356237 | 0.98 | HSD17B10 (0.41) | HSD17B10HTTMMP2ALDH1A1HPGD | |
| SCHEMBL504216 | 0.86 | CA12 (0.46) | ALDH1A1HPGDTAS2R14CA12CA1 | |
| SCHEMBL4095197 | 0.85 | PTGS1 (0.39) | HSD17B10HTTALDH1A1HPGDKDM4E | |
| SCHEMBL23908702 | 0.82 | ALDH1A1 (0.51) | ALDH1A1HPGDTAS2R14CA12CA1 | |
| Hydrochloric Acid SCHEMBL9874294 | 0.81 | THRB (0.39) | HSD17B10HTTALDH1A1TAS2R14PTGS1 | |
| SCHEMBL10489765 | 0.81 | GLRA3 (0.46) | HSD17B10MMP2ALDH1A1KDM4ECA12 | |
| SCHEMBL8570598 | 0.80 | CFTR (0.49) | HSD17B10ALDH1A1HPGDKDM4ECFTR | |
| SCHEMBL11692958 | 0.79 | CFTR (0.46) | CFTRPTGS1PLK1LMNAGAA | |
| SCHEMBL1000014 | 0.79 | MMP2 (0.54) | HSD17B10MMP2ALDH1A1HPGDKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 169 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118184679-A | Photothermal agent and preparation method thereof, photothermal nanoparticle and preparation method thereof, insulating material and self-repairing method of insulating material | 中国石油天然气股份有限公司 | 2024-06-14 | — | — | CN | claimed |
| WO-2016071485-A1 | METHOD FOR DETERMINING THE COMPOSITION OF THE SUGAR MOIETY OF A SUGAR CONTAINING COMPOUND | DANMARKS TEKNISKE UNIVERSITET (DK) | 2016-05-12 | — | — | WO | claimed |
| US-20090306375-A1 | Process for production of 4(3H)-quinazolinone derivative | MSD K.K. (JP) | 2009-12-10 | — | — | US | claimed |
| US-20090131664-A1 | Method for Producing 4(3H)-Quinazolinone Derivative | MSD K.K. (JP) | 2009-05-21 | — | — | US | claimed |
| CN-101351459-A | Method for producing 4(3H)-quinazolinone derivative | BANYU PHARMA CO LTD (JP) | 2009-01-21 | — | — | CN | claimed |
| EP-1903040-A1 | METHOD FOR PRODUCING 4(3H)-QUINAZOLINONE DERIVATIVE | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2008-03-26 | — | — | EP | claimed |
| EP-1900733-A1 | PROCESS FOR PRODUCTION OF 4(3H)-QUINAZOLINONE DERIVATIVE | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2008-03-19 | — | — | EP | claimed |
| EP-3968404-B1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORP (US) | 2026-04-01 | — | — | EP | disclosed |
| EP-4678641-A1 | QUINOLINONE COMPOUND AND NAPHTHYRIDINONE COMPOUND AND USE THEREOF | Shanghai Helioson Pharmaceutical Co., Ltd. (CN) | 2026-01-14 | — | — | EP | disclosed |
| CN-119585247-A | Bicyclic heterocyclic amide inhibitors of nav1.8 for the treatment of pain | 赛特温治疗公司 | 2025-03-07 | — | — | CN | disclosed |
| EP-4514789-A1 | <SUP2/>? <SUB2/>?V?BICYCLIC HETEROCYCLIC AMIDE INHIBITORS OF NA1.8 FOR THE TREATMENT OF PAIN | SiteOne Therapeutics, Inc. (US) | 2025-03-05 | — | — | EP | disclosed |
| US-20240397810-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2024-11-28 | — | — | US | disclosed |
| US-12082485-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2024-09-03 | — | — | US | disclosed |
| CN-1556705-A | 7,8,9,10-tetrahydro-6H-azepino, 6,7,8,9-tetrahydro-pyrido and 2,3-dihydro-2H-pyrrolo[2,1-b]-quinazolinone derivatives | ������˹ҩƷ��˾ | 2004-12-22 | — | — | CN | disclosed |
| WO-2004004733-A1 | 7,8,9,10-TETRAHYDRO-6H-AZEPINO, 6,7,8,9-TETRAHYDRO-PYRIDO AND 2,3-DIHYDRO-2H-PYRROLO[2,1-B]-QUINAZOLINONE DERIVATIVES | ACTELION PHARMACEUTICALS LTD. (CH) | 2004-01-15 | — | — | WO | disclosed |
| WO-2003106435-A1 | FUSED-RING PYRIMIDIN-4(3H)-ONE DERIVATIVES, PROCESSES FOR THE PREPARATION AND USES THEREOF | SANKYO COMPANY, LIMITED (JP) | 2003-12-24 | — | — | WO | disclosed |
| EP-0572863-A1 | CNS pyrazinoindoles | F. HOFFMANN-LA ROCHE AG (CH) | 1993-12-08 | — | — | EP | disclosed |
| US-RE31617-E | ANTICOAGULANTS; HYPOTENSIVE AND BRONCHODILATOR AGENTS | BRISTOL-MYERS COMPANY (US) | 1984-06-26 | — | — | US | disclosed |
| US-4307113-A | TREATMENT OF DIABETES | SANDOZ, INC. (US) | 1981-12-22 | — | — | US | disclosed |
| US-3932407-A | BRONCHODILATORS, HYPOTENSIVE AGENTS, ANTICOAGULANTS | BRISTOL-MYERS COMPANY (US) | 1976-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12082485-B2 | Organic electroluminescent materials and devices | ORC3, OCIAD1, ICOSLG | HSD17B10 4181/4885HTT 4451/4885MMP2 4757/4885 |
| US-20240397810-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | ORC3, OCIAD1, ICOSLG | HSD17B10 4181/4885HTT 4451/4885MMP2 4757/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.